Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Progyny, Inc. - Common Stock (NQ:PGNY)

23.63 -0.90 (-3.67%)
Streaming Delayed Price Updated: 10:23 AM EST, Jan 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Progyny, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Progyny Inc (NASDAQ:PGNY) Combines Strong Fundamentals with Bullish Technical Setup ↗
Via Chartmill
News headline image
Progyny (PGNY) Stock Is Up, What You Need To Know
Shares of fertility benefits company Progyny (NASDAQ:PGNY) jumped 3.3% in the afternoon session after Citizens upgraded the fertility benefits company's stock from Market Perform to Market Outperform,... 
Via StockStory
Topics Artificial Intelligence Supply Chain
News headline image
1 Profitable Stock to Consider Right Now and 2 We Avoid
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
News headline image
3 Hyped Up Stocks That Concern Us
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial... 
Via StockStory
News headline image
Earnings Scheduled For November 6, 2025 ↗
 
Via Benzinga
News headline image
Progyny (PGNY) Stock Is Up, What You Need To Know
Shares of fertility benefits company Progyny (NASDAQ:PGNY) jumped 4.9% in the morning session after an analyst at Keybanc maintained a positive rating on the stock and raised its price target. 
Via StockStory
Topics Artificial Intelligence Economy Supply Chain
News headline image
2 Reasons PGNY is Risky and 1 Stock to Buy Instead
Over the past six months, Progyny has been a great trade, beating the S&P 500 by 5.2%. Its stock price has climbed to $25.68, representing a healthy 16.4% increase. This was partly thanks to its solid... 
Via StockStory
Topics Economy Stocks Supply Chain
News headline image
3 Small-Cap Stocks with Warning Signs
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small... 
Via StockStory
Topics Bonds
News headline image
1 Safe-and-Steady Stock with Promising Prospects and 2 We Ignore
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. 
Via StockStory
News headline image
PROGYNY INC (NASDAQ:PGNY) Emerges as a Top Affordable Growth Stock Pick ↗
PROGYNY (PGNY) exemplifies the GARP strategy with strong earnings growth, a fair PEG ratio, and a robust, debt-free balance sheet. 
Via Chartmill
News headline image
3 Healthcare Stocks We Approach with Caution
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have... 
Via StockStory
Topics Stocks
News headline image
3 Healthcare Stocks We’re Skeptical Of
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 15.6% over... 
Via StockStory
Topics Stocks
News headline image
3 Cash-Heavy Stocks That Fall Short
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow. 
Via StockStory
News headline image
1 Russell 2000 Stock with Impressive Fundamentals and 2 Facing Headwinds
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these... 
Via StockStory
News headline image
2 Stocks Under $50 on Our Watchlist and 1 We Find Risky
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to... 
Via StockStory
News headline image
3 Value Stocks We Find Risky
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued... 
Via StockStory
News headline image
3 Hyped Up Stocks Walking a Fine Line
Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such as new products and positive media coverage... 
Via StockStory
News headline image
CEO Peter Anevski Buys $1.9 Million of Progyny Stock: Should Investors Buy Too? ↗
Is the CEO's latest purchase a buy signal for investors? 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Progyny (PGNY) Q3 2025 Earnings Call Transcript ↗
Progyny (PGNY) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Merit Medical Systems, Globus Medical, Tenet Healthcare, Progyny, and IQVIA Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated... 
Via StockStory
Topics Economy
News headline image
1 Unpopular Stock That Deserves Some Love and 2 Facing Headwinds
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other... 
Via StockStory
News headline image
A Look Back at Health Insurance Providers Stocks’ Q3 Earnings: Progyny (NASDAQ:PGNY) Vs The Rest Of The Pack
Let’s dig into the relative performance of Progyny (NASDAQ:PGNY) and its peers as we unravel the now-completed Q3 health insurance providers earnings season. 
Via StockStory
Topics Artificial Intelligence Economy Fraud
News headline image
5 Must-Read Analyst Questions From Progyny’s Q3 Earnings Call
Progyny’s third quarter was marked by strong top-line and profitability outperformance, which drew a positive market response. Management attributed these results to robust new client acquisition, the... 
Via StockStory
Topics Earnings Workforce
News headline image
3 Inflated Stocks with Warning Signs
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial... 
Via StockStory
News headline image
This AT&T Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday ↗
 
Via Benzinga
News headline image
Why Progyny Stock Is Soaring Today ↗
Progyny generates nearly $200 million in free cash flow annually and holds over $300 million in cash, yet it has a market cap of only $1.9 billion. It could be a bargain as stock-based compensation... 
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
PGNY Q3 Deep Dive: Product Expansion and Client Diversification Drive Momentum
Fertility benefits company Progyny (NASDAQ:PGNY) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 9.3% year on year to $313.3 million. Revenue guidance for the full... 
Via StockStory
News headline image
PROGYNY INC (NASDAQ:PGNY) Q3 2025 Earnings Beat Estimates and Boost Full-Year Outlook ↗
Progyny (PGNY) Q3 2025 earnings beat estimates with $313.3M in revenue and $0.45 EPS. The company raised its full-year guidance, driving a positive market reaction. 
Via Chartmill
Topics Earnings
News headline image
Progyny (NASDAQ:PGNY) Reports Upbeat Q3, Stock Soars
Fertility benefits company Progyny (NASDAQ:PGNY) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 9.3% year on year to $313.3 million. Revenue guidance for the full... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.